These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

220 related articles for article (PubMed ID: 26318678)

  • 1. Delineating the deranged immune system in the antiphospholipid syndrome.
    van den Hoogen LL; van Roon JA; Radstake TR; Fritsch-Stork RD; Derksen RH
    Autoimmun Rev; 2016 Jan; 15(1):50-60. PubMed ID: 26318678
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antiphospholipid syndrome: 30 years and our contribution.
    Koike T
    Int J Rheum Dis; 2015 Feb; 18(2):233-41. PubMed ID: 25524556
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Crassolide Suppresses Dendritic Cell Maturation and Attenuates Experimental Antiphospholipid Syndrome.
    Lin CC; Chang YK; Lin SC; Su JH; Chao YH; Tang KT
    Molecules; 2021 Apr; 26(9):. PubMed ID: 33923336
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Role of TLR4 on B Cell Activation and Anti-
    Cheng S; Wang H; Zhou H
    J Immunol Res; 2016; 2016():1719720. PubMed ID: 27868072
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical characterization of antiphospholipid syndrome by detection of IgG antibodies against β2 -glycoprotein i domain 1 and domain 4/5: ratio of anti-domain 1 to anti-domain 4/5 as a useful new biomarker for antiphospholipid syndrome.
    Andreoli L; Chighizola CB; Nalli C; Gerosa M; Borghi MO; Pregnolato F; Grossi C; Zanola A; Allegri F; Norman GL; Mahler M; Meroni PL; Tincani A
    Arthritis Rheumatol; 2015 May; 67(8):2196-204. PubMed ID: 25939498
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Beta2-glycoprotein I: antiphospholipid syndrome and T-cell reactivity.
    Kuwana M
    Thromb Res; 2004; 114(5-6):347-55. PubMed ID: 15507264
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Autoantibodies to beta2-glycoprotein I in systemic lupus erythematosus and primary antiphospholipid antibody syndrome: clinical correlations in comparison with other antiphospholipid antibody tests.
    Day HM; Thiagarajan P; Ahn C; Reveille JD; Tinker KF; Arnett FC
    J Rheumatol; 1998 Apr; 25(4):667-74. PubMed ID: 9558167
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Anti-beta2 glycoprotein I-beta2 glycoprotein I] immune complexes in patients with antiphospholipid syndrome and other autoimmune diseases.
    Biasiolo A; Rampazzo P; Brocco T; Barbero F; Rosato A; Pengo V
    Lupus; 1999; 8(2):121-6. PubMed ID: 10192506
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Systemic antiphospholipid syndrome and atherosclerosis.
    Jara LJ; Medina G; Vera-Lastra O
    Clin Rev Allergy Immunol; 2007 Apr; 32(2):172-7. PubMed ID: 17916989
    [TBL] [Abstract][Full Text] [Related]  

  • 10. T cells that are autoreactive to beta2-glycoprotein I in patients with antiphospholipid syndrome and healthy individuals.
    Hattori N; Kuwana M; Kaburaki J; Mimori T; Ikeda Y; Kawakami Y
    Arthritis Rheum; 2000 Jan; 43(1):65-75. PubMed ID: 10643701
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The immunology of atherothrombosis in the antiphospholipid syndrome: antigen presentation and lipid intracellular accumulation.
    Matsuura E; Kobayashi K; Matsunami Y; Lopez LR
    Autoimmun Rev; 2009 May; 8(6):500-5. PubMed ID: 19171205
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tolerogenic dendritic cells specific for β2-glycoprotein-I Domain-I, attenuate experimental antiphospholipid syndrome.
    Zandman-Goddard G; Pierangeli SS; Gertel S; Blank M
    J Autoimmun; 2014 Nov; 54():72-80. PubMed ID: 24972993
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Beta 2 glycoprotein I and neutrophil extracellular traps: Potential bridge between innate and adaptive immunity in anti-phospholipid syndrome.
    Grossi C; Capitani N; Benagiano M; Baldari CT; Della Bella C; Macor P; Tedesco F; Borghi MO; Maugeri N; D'Elios MM; Meroni PL
    Front Immunol; 2022; 13():1076167. PubMed ID: 36700193
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The dual role of innate immunity in antiphospholipid syndrome and systemic lupus erythematosus.
    Salem D; Subang R; Laplante P; Levine JS; Rauch J
    Lupus; 2014 Oct; 23(12):1327-31. PubMed ID: 25228740
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Release of neutrophil extracellular traps by neutrophils stimulated with antiphospholipid antibodies: a newly identified mechanism of thrombosis in the antiphospholipid syndrome.
    Yalavarthi S; Gould TJ; Rao AN; Mazza LF; Morris AE; Núñez-Álvarez C; Hernández-Ramírez D; Bockenstedt PL; Liaw PC; Cabral AR; Knight JS
    Arthritis Rheumatol; 2015 Nov; 67(11):2990-3003. PubMed ID: 26097119
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Anti-beta2-glycoprotein I antibodies in pediatric systemic lupus erythematosus and antiphospholipid syndrome.
    von Scheven E; Glidden DV; Elder ME
    Arthritis Rheum; 2002 Aug; 47(4):414-20. PubMed ID: 12209489
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Diagnosis and management of the antiphospholipid syndrome.
    Chaturvedi S; McCrae KR
    Blood Rev; 2017 Nov; 31(6):406-417. PubMed ID: 28784423
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical significance of anti-domain 1 β2-glycoprotein I antibodies in antiphospholipid syndrome.
    Iwaniec T; Kaczor MP; Celińska-Löwenhoff M; Polański S; Musiał J
    Thromb Res; 2017 May; 153():90-94. PubMed ID: 28363116
    [TBL] [Abstract][Full Text] [Related]  

  • 19. TLR4 is involved in the pathogenic effects observed in a murine model of antiphospholipid syndrome.
    Xie H; Kong X; Zhou H; Xie Y; Sheng L; Wang T; Xia L; Yan J
    Clin Immunol; 2015 Oct; 160(2):198-210. PubMed ID: 26065621
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antiphospholipid syndrome: pathogenesis and a window of treatment opportunities in the future.
    Mehdi AA; Uthman I; Khamashta M
    Eur J Clin Invest; 2010 May; 40(5):451-64. PubMed ID: 20345380
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.